135 related articles for article (PubMed ID: 37647563)
1. Evaluation of (2S,4S)-4-[
Huang Y; Liu Y; Li C; Li Z; Chen H; Zhang L; Liang Y; Wu Z
Mol Pharm; 2023 Oct; 20(10):5195-5205. PubMed ID: 37647563
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of a Novel [
Huang Y; Li C; Li Z; Xie Y; Chen H; Li S; Liang Y; Wu Z
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895948
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Precursor Synthesis Conditions of (2S,4S)4-[
Huang Y; Zhang L; Wang M; Li C; Zheng W; Chen H; Liang Y; Wu Z
Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 36015094
[TBL] [Abstract][Full Text] [Related]
4. PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[
Pollard AC; Paolillo V; Radaram B; Qureshy S; Li L; Maity T; Wang L; Uddin MN; Wood CG; Karam JA; Pagel MD; Piwnica-Worms D; Millward SW; Fowlkes NW; Norton W; Engel BJ; Pisaneschi F; Zacharias NM
Mol Imaging Biol; 2022 Dec; 24(6):959-972. PubMed ID: 35732988
[TBL] [Abstract][Full Text] [Related]
5. PET Imaging of
Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z
Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631
[TBL] [Abstract][Full Text] [Related]
6. (2S, 4R)-4-[
Miner MW; Liljenbäck H; Virta J; Merisaari J; Oikonen V; Westermarck J; Li XG; Roivainen A
Mol Imaging Biol; 2020 Aug; 22(4):969-978. PubMed ID: 31993927
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and preliminary evaluation of a novel glutamine derivative: (2S,4S)4-[
Huang Y; Liu S; Wu R; Zhang L; Zhang Y; Hong H; Zhang A; Xiao H; Liu Y; Wu Z; Zhu L; Kung HF
Bioorg Med Chem Lett; 2019 May; 29(9):1047-1050. PubMed ID: 30871772
[TBL] [Abstract][Full Text] [Related]
8. [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.
Wu Z; Zha Z; Li G; Lieberman BP; Choi SR; Ploessl K; Kung HF
Mol Pharm; 2014 Nov; 11(11):3852-66. PubMed ID: 25095908
[TBL] [Abstract][Full Text] [Related]
9. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
Lieberman BP; Ploessl K; Wang L; Qu W; Zha Z; Wise DR; Chodosh LA; Belka G; Thompson CB; Kung HF
J Nucl Med; 2011 Dec; 52(12):1947-55. PubMed ID: 22095958
[TBL] [Abstract][Full Text] [Related]
10. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
Front Immunol; 2022; 13():821423. PubMed ID: 35145523
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Fluorination at the 4 position alters the substrate behavior of L-glutamine and L-glutamate: Implications for positron emission tomography of neoplasias.
Jeitner TM; Kristoferson E; Azcona JA; Pinto JT; Stalnecker C; Erickson JW; Kung HF; Li J; Ploessl K; Cooper AJL
J Fluor Chem; 2016 Dec; 192(A):58-67. PubMed ID: 28546645
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Evaluation of [
Zheng W; Huang Y; Xie Y; Yang T; Cheng X; Chen H; Li C; Jiang Z; Yu Z; Li Z; Zhang L; Yuan L; Liu Y; Liang Y; Wu Z
Mol Pharm; 2024 May; 21(5):2606-2621. PubMed ID: 38606716
[TBL] [Abstract][Full Text] [Related]
14. KRAS Mutation Detection with (2
Liu S; Liu F; Hou X; Zhang Q; Ren Y; Zhu H; Yang Z; Xu X
Mol Pharm; 2024 Apr; 21(4):2034-2042. PubMed ID: 38456403
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[
Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H
Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Imaging of Glutamine in Cancer.
Zhu L; Ploessl K; Zhou R; Mankoff D; Kung HF
J Nucl Med; 2017 Apr; 58(4):533-537. PubMed ID: 28232608
[TBL] [Abstract][Full Text] [Related]
17. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of
Dunphy MPS; Harding JJ; Venneti S; Zhang H; Burnazi EM; Bromberg J; Omuro AM; Hsieh JJ; Mellinghoff IK; Staton K; Pressl C; Beattie BJ; Zanzonico PB; Gerecitano JF; Kelsen DP; Weber W; Lyashchenko SK; Kung HF; Lewis JS
Radiology; 2018 May; 287(2):667-675. PubMed ID: 29388903
[TBL] [Abstract][Full Text] [Related]
18. Side Chain Optimization Remarkably Enhances the in Vivo Stability of
Chen J; Li C; Hong H; Liu H; Wang C; Xu M; Han Y; Liu Z
Mol Pharm; 2019 Dec; 16(12):5035-5041. PubMed ID: 31670970
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of [
Wu R; Liu S; Liu Y; Sun Y; Cheng X; Huang Y; Yang Z; Wu Z
Eur J Med Chem; 2019 Dec; 183():111730. PubMed ID: 31563014
[TBL] [Abstract][Full Text] [Related]
20. Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine.
Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Zhu L; Li N; Kung HF; Yang Z
Clin Nucl Med; 2018 Nov; 43(11):e392-e399. PubMed ID: 30179907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]